Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis.

Gastro Hep Adv · 2023 · PMC10073076 · PMID 37360678

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

At 3 months post-D2, receipt of the BNT162b2 vaccine series was associated with a 49% lower chance of having high-titer antibody response (IRR 0.51; 95% CI: 0.31–0.85) and immunosuppressant use was associated with a 35% lower chance of having high-titer antibody response (IRR 0.65; 95% CI: 0.39–1.09), but this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.